These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1017 related articles for article (PubMed ID: 24352465)
1. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465 [TBL] [Abstract][Full Text] [Related]
2. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells. Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286 [TBL] [Abstract][Full Text] [Related]
3. Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein. Asante EA; Linehan JM; Smidak M; Tomlinson A; Grimshaw A; Jeelani A; Jakubcova T; Hamdan S; Powell C; Brandner S; Wadsworth JD; Collinge J PLoS Pathog; 2013; 9(9):e1003643. PubMed ID: 24086135 [TBL] [Abstract][Full Text] [Related]
4. Prion protein transgenes and the neuropathology in prion diseases. DeArmond SJ; Prusiner SB Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493 [TBL] [Abstract][Full Text] [Related]
5. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106. Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549 [TBL] [Abstract][Full Text] [Related]
6. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574 [TBL] [Abstract][Full Text] [Related]
7. Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity. Harrison CF; Lawson VA; Coleman BM; Kim YS; Masters CL; Cappai R; Barnham KJ; Hill AF J Biol Chem; 2010 Jun; 285(26):20213-23. PubMed ID: 20356832 [TBL] [Abstract][Full Text] [Related]
8. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. Timmes AG; Moore RA; Fischer ER; Priola SA PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256 [TBL] [Abstract][Full Text] [Related]
10. Prion infection of mouse neurospheres. Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413 [TBL] [Abstract][Full Text] [Related]
11. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation. Shoup D; Priola SA Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187 [TBL] [Abstract][Full Text] [Related]
12. Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes. Choi YP; Head MW; Ironside JW; Priola SA Am J Pathol; 2014 Dec; 184(12):3299-307. PubMed ID: 25280631 [TBL] [Abstract][Full Text] [Related]
13. A transmembrane form of the prion protein in neurodegenerative disease. Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375 [TBL] [Abstract][Full Text] [Related]
14. Protein misfolding cyclic amplification of prions. Saunders SE; Bartz JC; Shikiya RA J Vis Exp; 2012 Nov; (69):. PubMed ID: 23168797 [TBL] [Abstract][Full Text] [Related]
15. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein. Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746 [TBL] [Abstract][Full Text] [Related]
16. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion. Hara H; Sakaguchi S Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321 [TBL] [Abstract][Full Text] [Related]
18. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP. Munoz-Montesino C; Larkem D; Barbereau C; Igel-Egalon A; Truchet S; Jacquet E; Nhiri N; Moudjou M; Sizun C; Rezaei H; Béringue V; Dron M J Biol Chem; 2020 Oct; 295(41):14025-14039. PubMed ID: 32788216 [TBL] [Abstract][Full Text] [Related]
19. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases. Rossetti G; Cong X; Caliandro R; Legname G; Carloni P J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662 [TBL] [Abstract][Full Text] [Related]